Ticagrelor recalls
The FDA has published 2 recalls involving Ticagrelor since 2017. The latest was reported on 2 Jun 2021. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I150% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 1 50%Class III 0 0%
Why ticagrelor is recalled
Companies
By year
All ticagrelor recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Brilinta ticagrelar tablets 60 mg recalled by Cardinal HealthBrilinta | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS I | Brilinta (ticagrelor) tablets, 90 mg Professional Sample recalledBrilinta | AstraZeneca Pharmaceuticals | Other | Nationwide |
Should you stop taking Ticagrelor?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.